Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. j. med. biol. res ; 40(8): 1101-1109, Aug. 2007. tab, ilus
Artículo en Inglés | LILACS | ID: lil-456807

RESUMEN

Children with chronic renal failure in general present growth retardation that is aggravated by corticosteroids. We describe here the effects of methylprednisolone (MP) and recombinant human growth hormone (rhGH) on the growth plate (GP) of uremic rats. Uremia was induced by subtotal nephrectomy in 30-day-old rats, followed by 20 IU kg-1 day-1 rhGH (N = 7) or 3 mg kg-1 day-1 MP (N = 7) or 20 IU kg-1 day-1 rhGH + 3 mg kg-1 day-1 MP (N = 7) treatment for 10 days. Control rats with intact renal function were sham-operated and treated with 3 mg kg-1 day-1 MP (N = 7) or vehicle (N = 7). Uremic rats (N = 7) were used as untreated control animals. Structural alterations in the GP and the expression of anti-proliferating cell nuclear antigen (PCNA) and anti-insulin-like growth factor I (IGF-I) by epiphyseal chondrocytes were evaluated. Uremic MP rats displayed a reduction in the proliferative zone height (59.08 ± 4.54 vs 68.07 ± 7.5 æm, P < 0.05) and modifications in the microarchitecture of the GP. MP and uremia had an additive inhibitory effect on the proliferative activity of GP chondrocytes, lowering the expression of PCNA (19.48 ± 11.13 vs 68.64 ± 7.9 percent in control, P < 0.0005) and IGF-I (58.53 ± 0.96 vs 84.78 ± 2.93 percent in control, P < 0.0001), that was counteracted by rhGH. These findings suggest that in uremic rats rhGH therapy improves longitudinal growth by increasing IGF-I synthesis in the GP and by stimulating chondrocyte proliferation.


Asunto(s)
Animales , Femenino , Humanos , Ratas , Glucocorticoides/farmacología , Placa de Crecimiento/efectos de los fármacos , Hormona de Crecimiento Humana/farmacología , Metilprednisolona/farmacología , Uremia/metabolismo , Autoanticuerpos/metabolismo , Proliferación Celular , Condrocitos/efectos de los fármacos , Placa de Crecimiento/metabolismo , Placa de Crecimiento/patología , Factor I del Crecimiento Similar a la Insulina/metabolismo , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas Wistar , Tibia/efectos de los fármacos , Tibia/patología , Uremia/patología
2.
Petropolis; Vozes; 19 ed; 2000. 86 p. ilus.
Monografía en Portugués | LILACS, SES-SP | ID: lil-407765
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA